Insider Trading & Ownership - Harsch Mutya

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Harsch Mutya
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-03-20
Purchase
2023-03-22
4:01 pm
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
10,000 $2.5 $25,000 22,721
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-03-31
Tax Withholding
2025-04-02
4:15 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
CHIEF LEGAL OFFICER AND GC
8,828 $1.58 135,501
(Direct)
View
2025-01-21
Option Award
2025-01-23
4:15 pm
N/A
2035-01-20
VYNE Therapeutics Inc. VYNE Harsch Mutya
CHIEF LEGAL OFFICER AND GC
230,000 $0 230,000
(Direct)
View
2024-12-31
Tax Withholding
2025-01-02
5:45 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
CHIEF LEGAL OFFICER AND GC
4,697 $3.35 144,329
(Direct)
View
2024-09-30
Tax Withholding
2024-10-02
4:15 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
CHIEF LEGAL OFFICER AND GC
105 $1.88 149,026
(Direct)
View
2024-07-01
Tax Withholding
2024-07-03
4:15 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
CHIEF LEGAL OFFICER AND GC
143 $1.92 149,131
(Direct)
View
2024-04-01
Tax Withholding
2024-04-03
5:04 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
CHIEF LEGAL OFFICER AND GC
161 $3.08 149,274
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:20 pm
N/A
2033-12-31
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
62,500 $0 211,935
(Direct)
View
2024-01-02
Tax Withholding
2024-01-03
5:20 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
161 $2.28 211,935
(Direct)
View
2023-12-13
Option Award
2023-12-15
5:09 pm
N/A
2033-12-12
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
62,500 $0 149,596
(Direct)
View
2023-10-02
Tax Withholding
2023-10-04
4:21 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,154 $3.83 24,596
(Direct)
View
2023-06-30
Tax Withholding
2023-07-05
4:32 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
157 $4.1 25,750
(Direct)
View
2023-05-31
Option Award
2023-06-02
4:34 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
3,664 $3.4563 25,907
(Direct)
View
2023-03-31
Tax Withholding
2023-04-04
5:03 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
478 $3.08 22,243
(Direct)
View
2022-12-31
Tax Withholding
2023-01-04
5:12 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,813 $0.15 229,144
(Direct)
View
2022-09-30
Tax Withholding
2022-10-04
5:04 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,813 $0.223 230,957
(Direct)
View
2022-06-30
Tax Withholding
2022-07-05
5:00 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,813 $0.389 232,770
(Direct)
View
2022-06-03
Option Award
2022-06-07
5:36 pm
N/A
2032-06-02
Satsuma Pharmaceuticals Inc. STSA Harsch Mutya
Director
30,000 $0 30,000
(Direct)
View
2022-03-31
Tax Withholding
2022-04-04
5:09 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
3,630 $0.65 234,583
(Direct)
View
2022-03-17
Option Award
2022-03-18
5:09 pm
N/A
2032-03-17
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
75,000 $0 313,213
(Direct)
View
2021-12-31
Tax Withholding
2022-01-04
4:40 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,484 $1.02 163,213
(Direct)
View
2021-10-11
Option Award
2021-10-12
5:17 pm
N/A
2031-10-11
Satsuma Pharmaceuticals Inc. STSA Harsch Mutya
Director
40,000 $0 40,000
(Direct)
View
2021-09-30
Tax Withholding
2021-10-01
5:11 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,484 $1.39 164,697
(Direct)
View
2021-09-02
Option Award
2021-09-03
5:34 pm
N/A
2031-09-02
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
121,719 $0 227,041
(Direct)
View
2021-06-30
Tax Withholding
2021-07-02
4:36 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
3,551 $3.51 105,322
(Direct)
View
2021-03-31
Tax Withholding
2021-04-02
12:14 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,765 $6.84 108,873
(Direct)
View
2021-02-22
Option Award
2021-02-24
4:38 pm
N/A
2031-02-22
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
97,375 $0 178,800
(Direct)
View
2020-12-31
Tax Withholding
2021-01-05
4:32 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,822 $1.58 325,703
(Direct)
View
2020-11-30
Option Award
2020-12-02
4:31 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
10,460 $1.445 327,525
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
4:31 pm
N/A
N/A
VYNE Therapeutics Inc. VYNE Harsch Mutya
Chief Legal Officer and GC
1,822 $1.66 317,065
(Direct)
View
2020-06-30
Tax Withholding
2020-07-02
4:24 pm
N/A
N/A
Menlo Therapeutics Inc. MNLO Harsch Mutya
Chief Legal Officer and GC
1,822 $1.73 318,887
(Direct)
View
2020-05-06
Option Award
2020-05-08
5:53 pm
N/A
2030-05-06
Menlo Therapeutics Inc. MNLO Harsch Mutya
Chief Legal Officer and GC
150,000 $0 470,712
(Direct)
View